Alembic Pharmaceuticals Ltd - Share Price
APLLTD
Alembic Pharmaceuticals LtdFinancials
Alembic Pharmaceuticals LtdNews & Updates
Alembic Pharma receives USFDA approval for Lurasidone Hydrochloride tablets
May 14,2021 04:39 PM
Lurasidone Hydrochloride Tablets are indicated for monotherapy treatment of adult and pediatric patients (10 to 17 years) with maj
Alembic Pharmaceuticals receives USFDA approval for Lurasidone Hydrochloride Tablets May 14,2021
Alembic Pharma bags USFDA nod for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution May 05,2021
Board of Alembic Pharmaceuticals recommends final dividend May 04,2021
Alembic Pharmaceuticals JV Aleor receives USFDA approval for Metronidazole Gel May 04,2021
Aleor Dermaceuticals receives USFDA tentative approval for Metronidazole Gel May 04,2021
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 691.45 | 55.87 | 165,818.04 | 555.55 | 0.58 | 3,366.01 | 106.10 |
| Divis Laboratories Ltd | 4,020.55 | 57.45 | 106,771.46 | 461.24 | 0.40 | 1,656.48 | 313.47 |
| Dr Reddys Laboratories Ltd | 5,196.85 | 39.52 | 86,407.73 | 443.70 | 0.48 | 3,397.50 | 1,021.26 |
| Cipla Ltd | 904.05 | 27.41 | 72,912.69 | 698.93 | 0.44 | 3,689.88 | 233.60 |
| Cadila Healthcare Ltd | 617.15 | 35.02 | 63,175.16 | 140.30 | 0.57 | 1,822.20 | 118.38 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Alembic Pharmaceuticals LtdSummary & Reports
No Company Summary found
Registered Office
Alembic Road,,Vadodara, Gujarat,390003
Tell. : +91-0265-2280550
Website : http://www.alembicpharmaceuticals.com
Email : apl.investors@alembic.co.in
Registrar Office
B-102&103 Shangrila, Akota, Vadodara - 390 020 INDIA
Tell. : +91-265-2356573/23567
Website : www.linkintime.co.in
Email : vadodara@linktime.co.in
Reports by alembic-pharmaceuticals-ltd-share-price
Latest Release by alembic-pharmaceuticals-ltd-share-price
Result Express
May 15, 2021 02:02 AM
The company’s consolidated revenue stood at Rs1,018.15cr, up 21.21% yoy but down 9.66% qoq.
Shareholding Snapshot
Loading ...
| Mar - 2021 | |
|---|---|
| Promoter | - |
| Foreign | 0.51% |
| Indian | 68.97% |
| Total Promoter | 69.48% |
| Non Promoter | - |
| Institutions | 17.53% |
| Non-Institutions | 12.99% |
| Total Non-Promoter | 30.52% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Board Meeting
Exp. Date
04 May 2021
Annc. Date
20 Apr 2021
ALEMBIC PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Compa... More
Purpose
Board Meeting
Exp. Date
19 Jan 2021
Annc. Date
07 Jan 2021
ALEMBIC PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Compa... More
